Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Metadata
Title
The increase of antiglomerular basement membrane antibody following pauci-immune-type crescentic glomerulonephritis
Authors
Wataru Kitagawa
Naoto Miura
Harutaka Yamada
Kazuhiro Nishikawa
Arao Futenma
Hirokazu Imai
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
Clinical and Experimental Nephrology / Issue 1/2005
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-004-0334-7

Other articles of this Issue 1/2005

Clinical and Experimental Nephrology 1/2005 Go to the issue

ORIGINAL ARTICLE

Urinary excretion of liver fatty acid-binding protein in health-check participants

ORIGINAL ARTICLE

Hypocomplementemia and membranoproliferative glomeruloneophritis in children

REVIEW ARTICLE

Factors influencing the development of end-stage renal disease

ORIGINAL ARTICLE

Risk factors for bleeding complications in percutaneous renal biopsy

CASE REPORT

Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal

CASE REPORT

A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits